Welcome to our dedicated page for Aeva Technologies news (Ticker: aevaw), a resource for investors and traders seeking the latest updates and insights on Aeva Technologies stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Aeva Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Aeva Technologies's position in the market.
InterPrivate Acquisition Corp. (NYSE: IPV) announced the approval of all proposals related to its business combination with Aeva Technologies, Inc. at a special stockholder meeting on March 11, 2021. Aeva expects to receive approximately $563M in gross proceeds from the transaction, including $320 million from approved private placements. The closing of the business combination is anticipated on March 12, 2021, with shares to trade under the ticker symbols AEVA and AEVAW starting March 15, 2021.
FAQ
What is the current stock price of Aeva Technologies (aevaw)?
